Ashburner, M., C. A. Ball, J. A. Blake, D. Botstein, H. Butler, J. M. Cherry, A. P. Davis, K. Dolinski, S. S. Dwight, J. T. Eppig, M. A. Harris, D. P. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J. C. Matese, J. E. Richardson, M. Ringwald, G. M. Rubin and G. Sherlock (2000). "Gene ontology: tool for the unification of biology. The Gene Ontology Consortium." Nature genetics 25(1): 25-29.
Bense, R. D., C. Sotiriou, M. J. Piccart-Gebhart, J. Haanen, M. van Vugt, E. G. E. de Vries, C. P. Schröder and R. S. N. Fehrmann (2017). "Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer." J Natl Cancer Inst 109(1).
Burdelski, C., N. Jakani-Karimi, F. Jacobsen, C. Möller-Koop, S. Minner, R. Simon, G. Sauter, S. Steurer, T. S. Clauditz and W. Wilczak (2018). "IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues." Oncol Rep 39(1): 3-12.
Chatterji, P. and A. K. Rustgi (2018). "RNA Binding Proteins in Intestinal Epithelial Biology and Colorectal Cancer." Trends Mol Med 24(5): 490-506.
Chen, B., M. S. Khodadoust, C. L. Liu, A. M. Newman and A. A. Alizadeh (2018). "Profiling Tumor Infiltrating Immune Cells with CIBERSORT." Methods Mol Biol 1711: 243-259.
Comet, I., E. M. Riising, B. Leblanc and K. Helin (2016). "Maintaining cell identity: PRC2-mediated regulation of transcription and cancer." Nat Rev Cancer 16(12): 803-810.
Crea, F., E. M. Hurt, L. A. Mathews, S. M. Cabarcas, L. Sun, V. E. Marquez, R. Danesi and W. L. Farrar (2011). "Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer." Mol Cancer 10: 40.
de Bruin, R. G., T. J. Rabelink, A. J. van Zonneveld and E. P. van der Veer (2017). "Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease." Eur Heart J 38(18): 1380-1388.
Di, W., X. Weinan, L. Xin, Y. Zhiwei, G. Xinyue, T. Jinxue and L. Mingqi (2019). "Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7." Cell Death Dis 10(7): 514.
El-Serag, H. B. (2004). "Hepatocellular carcinoma: recent trends in the United States." Gastroenterology 127(5 Suppl 1): S27-S34.
Emran, A. A., A. Chatterjee, E. J. Rodger, J. C. Tiffen, S. J. Gallagher, M. R. Eccles and P. Hersey (2019). "Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy." Trends Immunol 40(4): 328-344.
Faviana, P., R. Marconcini, S. Ricci, L. Galli, P. Lippolis, F. Farci, M. Castagna and L. Boldrini (2019). "EZH2 Expression in Intestinal Neuroendocrine Tumors." Appl Immunohistochem Mol Morphol 27(9): 689-693.
Gerstberger, S., M. Hafner and T. Tuschl (2014). "A census of human RNA-binding proteins." Nat Rev Genet 15(12): 829-845.
Gong, Y., B. A. Woda and Z. Jiang (2014). "Oncofetal protein IMP3, a new cancer biomarker." Adv Anat Pathol 21(3): 191-200.
Jeong, H. M., J. Han, S. H. Lee, H. J. Park, H. J. Lee, J. S. Choi, Y. M. Lee, Y. L. Choi, Y. K. Shin and M. J. Kwon (2017). "ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells." Oncogenesis 6(11): e391.
Jin, Y., F. Zhang, Z. Ma and Z. Ren (2016). "MicroRNA 433 regulates nonsense-mediated mRNA decay by targeting SMG5 mRNA." BMC Mol Biol 17(1): 17.
Kanehisa, M., Y. Sato, M. Kawashima, M. Furumichi and M. Tanabe (2016). "KEGG as a reference resource for gene and protein annotation." Nucleic acids research 44(D1): D457-D462.
Liu, X., S. Wu, Y. Yang, M. Zhao, G. Zhu and Z. Hou (2017). "The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer." Biomed Pharmacother 95: 55-61.
Masuda, K. and Y. Kuwano (2019). "Diverse roles of RNA-binding proteins in cancer traits and their implications in gastrointestinal cancers." Wiley Interdiscip Rev RNA 10(3): e1520.
Nakano, S., Y. Eso, H. Okada, A. Takai, K. Takahashi and H. Seno (2020). "Recent Advances in Immunotherapy for Hepatocellular Carcinoma." Cancers 12(4).
Ohnishi, T., A. Yamashita, I. Kashima, T. Schell, K. R. Anders, A. Grimson, T. Hachiya, M. W. Hentze, P. Anderson and S. Ohno (2003). "Phosphorylation of hUPF1 induces formation of mRNA surveillance complexes containing hSMG-5 and hSMG-7." Mol Cell 12(5): 1187-1200.
Park, J. W., M. Chen, M. Colombo, L. R. Roberts, M. Schwartz, P. J. Chen, M. Kudo, P. Johnson, S. Wagner, L. S. Orsini and M. Sherman (2015). "Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study." Liver Int 35(9): 2155-2166.
Pereira, B., M. Billaud and R. Almeida (2017). "RNA-Binding Proteins in Cancer: Old Players and New Actors." Trends Cancer 3(7): 506-528.
Rhee, I. (2016). "Diverse macrophages polarization in tumor microenvironment." Arch Pharm Res 39(11): 1588-1596.
Rhodes, D. R., J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey and A. M. Chinnaiyan (2004). "ONCOMINE: a cancer microarray database and integrated data-mining platform." Neoplasia 6(1): 1-6.
Sauerbrei, W., P. Royston and H. Binder (2007). "Selection of important variables and determination of functional form for continuous predictors in multivariable model building." Stat Med 26(30): 5512-5528.
Sternberg, C. N. (2006). "Are nomograms better than currently available stage groupings for bladder cancer?" J Clin Oncol 24(24): 3819-3820.
Szulzewsky, F., A. Pelz, X. Feng, M. Synowitz, D. Markovic, T. Langmann, I. R. Holtman, X. Wang, B. J. Eggen, H. W. Boddeke, D. Hambardzumyan, S. A. Wolf and H. Kettenmann (2015). "Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1." PLoS One 10(2): e0116644.
Vikesaa, J., T. V. Hansen, L. Jønson, R. Borup, U. M. Wewer, J. Christiansen and F. C. Nielsen (2006). "RNA-binding IMPs promote cell adhesion and invadopodia formation." Embo j 25(7): 1456-1468.
Wang, Y., J. Li, Y. Xia, R. Gong, K. Wang, Z. Yan, X. Wan, G. Liu, D. Wu, L. Shi, W. Lau, M. Wu and F. Shen (2013). "Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy." J Clin Oncol 31(9): 1188-1195.
Wu, Y., H. Chen, Y. Chen, L. Qu, E. Zhang, Z. Wang, Y. Wu, R. Yang, R. Mao, C. Lu and Y. Fan (2019). "HPV shapes tumor transcriptome by globally modifying the pool of RNA binding protein-binding motif." Aging (Albany NY) 11(8): 2430-2446.
Xiao, G., L.-L. Jin, C.-Q. Liu, Y.-C. Wang, Y.-M. Meng, Z.-G. Zhou, J. Chen, X.-J. Yu, Y.-J. Zhang, J. Xu and L. Zheng (2019). "EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma." Journal for immunotherapy of cancer 7(1): 300-300.
Xiao, G., L. L. Jin, C. Q. Liu, Y. C. Wang, Y. M. Meng, Z. G. Zhou, J. Chen, X. J. Yu, Y. J. Zhang, J. Xu and L. Zheng (2019). "EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma." J Immunother Cancer 7(1): 300.
Xie, M., T. Ma, J. Xue, H. Ma, M. Sun, Z. Zhang, M. Liu, Y. Liu, S. Ju, Z. Wang and W. De (2019). "The long intergenic non-protein coding RNA 707 promotes proliferation and metastasis of gastric cancer by interacting with mRNA stabilizing protein HuR." Cancer Lett 443: 67-79.
Yu, G., L.-G. Wang, Y. Han and Q.-Y. He (2012). "clusterProfiler: an R package for comparing biological themes among gene clusters." Omics : a journal of integrative biology 16(5): 284-287.
Zhang, H., Y. Wang, J. Dou, Y. Guo, J. He, L. Li, X. Liu, R. Chen, R. Deng, J. Huang, R. Xie, X. Zhao and J. Yu (2019). "Acetylation of AGO2 promotes cancer progression by increasing oncogenic miR-19b biogenesis." Oncogene 38(9): 1410-1431.
Zheng, Z., W. Liang, D. Wang, P. M. Schroder, W. Ju, L. Wu, Z. Zheng, Y. Shang, Z. Guo and X. He (2015). "Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: a meta-analysis." International journal of cancer 136(6): E751-E759.
Zong, F. Y., X. Fu, W. J. Wei, Y. G. Luo, M. Heiner, L. J. Cao, Z. Fang, R. Fang, D. Lu, H. Ji and J. Hui (2014). "The RNA-binding protein QKI suppresses cancer-associated aberrant splicing." PLoS Genet 10(4): e1004289.